Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Lotz

Showing results (161-170 of 205) with videos related to

Pageof 21
Sort By:
Bone Marrow Transplantation|February 28, 2006
Post-operative sequential high-dose chemotherapy with haematopoietic stem cell support as front-line treatment in advanced ovarian cancer: a phase II multicentre studyA Gonçalves, R Delva, M Fabbro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 27, 2016
ESMO/ASCO recommendations for a Global Curriculum (GC) in medical oncology-edition 2016C Dittrich, M Kosty, S Jezdic, et al.
Transfusion|March 10, 2001
Cytokines and vascular cell adhesion molecule-1 in the blood of patients undergoing HPC mobilizationC Dosquet, Y Chen, J Makke, et al.
Chemistry & Biology|September 28, 2011
Expanded polyglutamine-binding peptoid as a novel therapeutic agent for treatment of Huntington's diseaseXuesong Chen, Jun Wu, Yuan Luo, et al.
European Journal of Cancer (Oxford, England : 1990)|May 4, 2001
High-dose intensity oxaliplatin added to the simplified bimonthly leucovorin and 5-fluorouracil regimen as second-line therapy for metastatic colorectal cancer (FOLFOX 7)F Maindrault-Goebel, A de Gramont, C Louvet, et al.
Bone Marrow Transplantation|May 24, 2005
High-dose chemotherapy with autologous haemopoietic support for advanced ovarian cancer in first complete remission: retrospective analysis from the Solid Tumour Registry of the European Group for Blood and Marrow Transplantation (EBMT)C Bengala, V Guarneri, J Ledermann, et al.
European Journal of Cancer (Oxford, England : 1990)|February 5, 2000
CPT-11 (irinotecan) addition to bimonthly, high-dose leucovorin and bolus and continuous-infusion 5-fluorouracil (FOLFIRI) for pretreated metastatic colorectal cancer. GERCORT André, C Louvet, F Maindrault-Goebel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 28, 2006
A phase II study of a paclitaxel and oxaliplatin combination in platinum-sensitive recurrent advanced ovarian cancer patientsP Viens, T Petit, A Yovine, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 8, 2001
High dose chemotherapy in ovarian cancerE Pujade-Lauraine, H Curé, C Battista, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|February 20, 2015
Current applications of PET imaging of sex hormone receptors with a fluorinated analogue of estradiol or of testosteroneJ N Talbot, J Gligorov, V Nataf, et al.
Pageof 21

Showing results (161-170 of 205) with videos related to

Sort By:
Pageof 21
Bone Marrow Transplantation|February 28, 2006
Post-operative sequential high-dose chemotherapy with haematopoietic stem cell support as front-line treatment in advanced ovarian cancer: a phase II multicentre studyA Gonçalves, R Delva, M Fabbro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 27, 2016
ESMO/ASCO recommendations for a Global Curriculum (GC) in medical oncology-edition 2016C Dittrich, M Kosty, S Jezdic, et al.
Transfusion|March 10, 2001
Cytokines and vascular cell adhesion molecule-1 in the blood of patients undergoing HPC mobilizationC Dosquet, Y Chen, J Makke, et al.
Chemistry & Biology|September 28, 2011
Expanded polyglutamine-binding peptoid as a novel therapeutic agent for treatment of Huntington's diseaseXuesong Chen, Jun Wu, Yuan Luo, et al.
European Journal of Cancer (Oxford, England : 1990)|May 4, 2001
High-dose intensity oxaliplatin added to the simplified bimonthly leucovorin and 5-fluorouracil regimen as second-line therapy for metastatic colorectal cancer (FOLFOX 7)F Maindrault-Goebel, A de Gramont, C Louvet, et al.
Bone Marrow Transplantation|May 24, 2005
High-dose chemotherapy with autologous haemopoietic support for advanced ovarian cancer in first complete remission: retrospective analysis from the Solid Tumour Registry of the European Group for Blood and Marrow Transplantation (EBMT)C Bengala, V Guarneri, J Ledermann, et al.
European Journal of Cancer (Oxford, England : 1990)|February 5, 2000
CPT-11 (irinotecan) addition to bimonthly, high-dose leucovorin and bolus and continuous-infusion 5-fluorouracil (FOLFIRI) for pretreated metastatic colorectal cancer. GERCORT André, C Louvet, F Maindrault-Goebel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 28, 2006
A phase II study of a paclitaxel and oxaliplatin combination in platinum-sensitive recurrent advanced ovarian cancer patientsP Viens, T Petit, A Yovine, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 8, 2001
High dose chemotherapy in ovarian cancerE Pujade-Lauraine, H Curé, C Battista, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|February 20, 2015
Current applications of PET imaging of sex hormone receptors with a fluorinated analogue of estradiol or of testosteroneJ N Talbot, J Gligorov, V Nataf, et al.
Pageof 21